We are live on
!
Find out more
NERM
New England Research & Management Portfolio holdings
AUM
$257M
1-Year Est. Return
25.66%
This Fund
S&P 500
This Quarter
Est. Return
+13.55%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$257M
AUM Growth
+$20.3M
(+8.6%)
Cap. Flow
-$3.38M
Cap. Flow
% of AUM
-1.32%
Top 10 Holdings %
Top 10 Hldgs %
33.42%
Holding
167
New
24
Increased
41
Reduced
51
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.37M |
| 2 |
Ulta Beauty
ULTA
|
+$2.18M |
| 3 |
ConocoPhillips
COP
|
+$2.04M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$1.97M |
| 5 |
Emerson Electric
EMR
|
+$1.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$4.77M |
| 2 |
Uber
UBER
|
+$3.19M |
| 3 |
Palo Alto Networks
PANW
|
+$2.27M |
| 4 |
CrowdStrike
CRWD
|
+$2.23M |
| 5 |
D.R. Horton
DHI
|
+$2.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.01% |
| 2 | Healthcare | 17.6% |
| 3 | Financials | 14.71% |
| 4 | Technology | 12.6% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Howmet Aerospace
HWM
$113B
| – | – |
-1,315
| Closed | -$303K |
|
152
Intuit
INTU
$86.5B
| – | – |
-601
| Closed | -$260K |
|
153
IQVIA
IQV
$38.7B
| – | – |
-2,880
| Closed | -$491K |
|
154
Intuitive Surgical
ISRG
$127B
| – | – |
-1,279
| Closed | -$590K |
|
155
Jacobs Solutions
J
$15.9B
| – | – |
-1,600
| Closed | -$204K |
|
156
Lennox International
LII
$14.4B
| – | – |
-585
| Closed | -$272K |
|
157
Lumentum
LITE
$55.5B
| – | – |
-750
| Closed | -$527K |
|
158
Medtronic
MDT
$109B
| – | – |
-5,513
| Closed | -$478K |
|
159
Nasdaq
NDAQ
$52.7B
| – | – |
-15,250
| Closed | -$1.29M |
|
160
ServiceNow
NOW
$115B
| – | – |
-2,550
| Closed | -$267K |
|
|
161
Palo Alto Networks
PANW
$270B
| – | – |
-14,154
| Closed | -$2.27M |
|
162
Insulet
PODD
$11.5B
| – | – |
-1,500
| Closed | -$315K |
|
163
Toll Brothers
TOL
$13.6B
| – | – |
-6,225
| Closed | -$850K |
|
164
Trane Technologies
TT
$100B
| – | – |
-2,100
| Closed | -$875K |
|
165
Take-Two Interactive
TTWO
$45.4B
| – | – |
-2,295
| Closed | -$453K |
|
|
166
Uber
UBER
$143B
| – | – |
-44,373
| Closed | -$3.19M |
|
167
Veralto
VLTO
$23B
| – | – |
-4,258
| Closed | -$376K |
|
Similar funds
GCCM
EBWM
HFRG
ACM
CCA
PHAM
TC
New England Research & Management's Q2 2026 Portfolio in Review
As of Q2 2026, New England Research & Management held 167 positions worth $257M, up 8.6% from $237M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
New England Research & Management's Q2 2026 filing shows 24 new, 41 increased, 51 reduced and 33 closed positions. Its largest new stake was Ulta Beauty: 4,303 shares worth $1.94M. The largest sale was Capital One, an estimated $4.77M.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- New England Research & Management's largest Q2 2026 buy was Ulta Beauty: 4,303 shares worth $1.94M.
- New England Research & Management added most to AstraZeneca in Q2 2026, an estimated $2.37M increase.
- New England Research & Management's biggest Q2 2026 reduction was Idexx Laboratories, cutting an estimated $1.82M.
- New England Research & Management fully exited Capital One in Q2 2026, selling an estimated $4.77M.
- New England Research & Management's ten largest holdings make up 33% of its $257M portfolio in Q2 2026.
- New England Research & Management opened 24 new positions and closed 33 in Q2 2026.
- New England Research & Management's portfolio value rose 8.6% quarter-over-quarter to $257M.
Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.